Nasdaq-listed Altamira Therapeutics has successfully navigated a strategic repositioning with the assistance of legal counsel from Walder Wyss. The innovative move involved the sale of a 51% stake in its subsidiary, Altamira Medica, to a Swiss
Tags :Iliana Djagova
Walder Wyss has incorporated four new counsels to the firm: Stefan Walder, Iliana Djagova, Joy Malka and Téo Genecand (photographed in order of mention). Stefan Walder is counsel in the corporate/M&A
AURELIUS, the alternative investment group, has announced last April the sale of Distrelec Group, a UK-based B2B distributor of electronic and technical components, to RS Group, a UK-based omni-channel provider of industrial product and
Climeworks signs an equity round of CHF 600 million (USD 650 million). The financing is co-led by Partners Group (acting on behalf of its clients) and GIC, with further participation from Baillie Gifford, Carbon Removal Partners, Global
The Heubach Group, in partnership with Sk Capital, announced today a definitive agreement to acquire Clariant’s pigments business. The combined business will operate under the Heubach name, creating a global pigments leader generating more
Colfax Corporation subsidiary DJO, has entered into a definitive agreement to expand DJO’s reconstructive business and acquire Mathys Bettlach (Mathys). Mathys shareholders have approved the sale of all shares to the mother company of
The team included partner Matthias Wolf (pictured), senior associate Iliana Djagova and associate Pascal Burgunder, and all of the firm's M&A department.
Lenz & Staehelin advises SoftwareONE in this transaction. The team included partner Matthias Wolf and senior associate Iliana Djagova of the firm's M&A department. They had already advised on the acquisition of the initial 40% stake
The team is led by Tino Gaberthüel (M&A - pictured) and includes among others Iliana Djagova and Pascal Burgunder (all M&A), Jürg Simon (IP), Fabiano Menghini (Real Estate) and Nicole Koch-Frey (
